Bristol-Myers Squibb Company (BMY)

The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders....

BofA Securities upgraded Bristol Myers Squibb & Co.  (NYSE: BMY), citing near-term catalysts....

Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and improving risk-reward outlook....

BMY shares are rebounding after a strong Q3, lifted by rising demand for Opdivo, Reblozyl and Camzyos, even as legacy drugs face generic pressure....

Pre-Market Stock Futures: Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard on Friday as investors began a big rotation last ...

Cullen Capital Management LLC lifted its position in Bristol Myers Squibb Company (NYSE: BMY) by 12.7% in the undefined quarter, according to the company in its most recent filing with the Securities ...

These two pharmaceutical giants have faced -- or will soon face -- patent cliffs. Both are innovative drugmakers, which should allow them to overcome this issue....

Chevron is an integrated energy company with an impressive yield and an impressive dividend history. Bristol Myers has a high yield, but the drugmaker is out of favor....

This article presents a diversified, fund-based portfolio targeting market-matching growth and a 6%+ income yield, with lower tech exposure than the S&P 500. The model portfolio, comprising 5 ETFs and...

AQR Capital Management LLC lifted its stake in Bristol Myers Squibb Company (NYSE: BMY) by 1.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange ...